Curis EV - Enterprise Value 2011-2026 | CRIS

Annual EV - Enterprise Value Curis

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
18.9 M	40.5 M	86.6 M	45.4 M	324 M	513 M	107 M	56.3 M	111 M	361 M	200 M	183 M	269 M	265 M	356 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
513 M	18.9 M	196 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Alterity Therapeutics Limited ATHE	-28.9 M	$ 4.3	8.4 %	$ 10.3 B	Australia
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
AlloVir ALVR	-55.1 M	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Akari Therapeutics, Plc AKTX	79.3 B	$ 5.26	2.7 %	$ 354 B	Britain
Aligos Therapeutics ALGS	82.6 M	$ 6.7	-12.53 %	$ 66.2 M	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA
Alnylam Pharmaceuticals ALNY	43.3 B	$ 315.2	-1.54 %	$ 41.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	-1.76 M	-	-18.52 %	$ 27.3 M	Britain
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Amphastar Pharmaceuticals AMPH	1.92 B	$ 22.46	2.98 %	$ 1.05 B	USA
Applied Therapeutics APLT	563 M	-	-	$ 8.42 M	USA
BioNTech SE BNTX	-4.91 B	$ 104.56	2.39 %	$ 27.2 B	Germany
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	647 M	$ 3.08	-	$ 5.07 M	Israel
Aeterna Zentaris AEZS	10.3 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
BioXcel Therapeutics BTAI	127 M	$ 1.19	11.23 %	$ 14.5 M	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	493 M	$ 1.39	2.96 %	$ 357 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	540 M	$ 4.35	2.0 %	$ 465 M	USA
AstraZeneca PLC AZN	59.6 B	-	-	$ 96.9 B	Britain
Arcutis Biotherapeutics ARQT	3.64 B	$ 24.45	1.07 %	$ 3.11 B	USA
Burford Capital Limited BUR	3.22 B	$ 4.88	4.5 %	$ 784 M	Britain
AIkido Pharma AIKI	9.53 M	-	1.93 %	$ 17.4 M	USA
Brainstorm Cell Therapeutics BCLI	11 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
Cabaletta Bio CABA	253 M	$ 3.34	-5.26 %	$ 336 M	USA
Autolus Therapeutics plc AUTL	629 M	$ 1.64	1.86 %	$ 436 M	Britain
Aptose Biosciences APTO	36.2 M	-	-45.71 %	$ 1.2 M	Canada
AVROBIO AVRO	-35.4 M	-	1083.1 %	$ 745 M	USA
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	270 M	-	-	$ 546 M	USA
Celldex Therapeutics CLDX	2.07 B	$ 35.15	3.81 %	$ 2.33 B	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Cidara Therapeutics CDTX	9.99 M	-	-	$ 1.41 B	USA
CymaBay Therapeutics CBAY	3.36 B	-	-	$ 3.45 B	USA
Allena Pharmaceuticals ALNA	-14.1 M	-	3.16 %	$ 1.9 M	USA